Clover Health Investments, Corp. (CLOV) Stock Overview
Explore Clover Health Investments, Corp.’s financial performance, market position, analyst ratings, and future outlook.
Clover Health Investments, Corp. (CLOV)
Key Financials
Key Financials
Market Cap
2.6B
P/E Ratio
291.47
EPS (TTM)
$0.04
ROE
0.04%
CLOV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Clover Health Investments, Corp. (NASDAQ: CLOV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Clover Health Investments, Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CLOV on the NASDAQ shows an RSI of 59.67, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.86 for the NASDAQ listing.
Key metrics behind Clover Health Investments, Corp.'s NASDAQ-traded stock include a P/E ratio of 291.47 and a market capitalization of 2.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLOV on the NASDAQ.